Tying Reimbursement to Outcomes Is an Ideal Strategy for PCSK9 Inhibitors
Sign Up to like & getrecommendations! Published in 2017 at "JAMA Cardiology"
DOI: 10.1001/jamacardio.2017.2959
Abstract: Overview Pay-for-performance programs, which seek to better align incentives between insurers and clinicians, are increasingly being used to improve quality without necessarily increasing spending. For example, under Medicare’s hospital value-based payment program, reimbursements are based… read more here.
Keywords: pcsk9 inhibitors; based pricing; outcomes based; reimbursement ... See more keywords
Association of Transcatheter Aortic Valve Replacement Reimbursement, New Technology Add-on Payment, and Procedure Volumes With Embolic Protection Device Use.
Sign Up to like & getrecommendations! Published in 2022 at "JAMA cardiology"
DOI: 10.1001/jamacardio.2022.2608
Abstract: Importance In the setting of uncertain efficacy and additional, unreimbursed cost, use of an embolic protection device (EPD) during transcatheter aortic valve replacement (TAVR) has had variable uptake. The Centers for Medicare & Medicaid Services… read more here.
Keywords: new technology; reimbursement; technology add; epd use ... See more keywords
Immediate Postpartum Long-Acting Reversible Contraceptive Use Following State-Specific Changes in Hospital Medicaid Reimbursement
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.37918
Abstract: Key Points Question Are Medicaid policies that reimburse hospitals for immediate postpartum long-acting reversible contraception (LARC) associated with increased provision of this service? Findings In this cross-sectional study of more than 3 million births in… read more here.
Keywords: postpartum; immediate postpartum; postpartum long; acting reversible ... See more keywords
Precision reimbursement for precision medicine: using real world evidence to evolve from trial-and-project to track-and-pay to learn-and-predict.
Sign Up to like & getrecommendations! Published in 2021 at "Clinical pharmacology and therapeutics"
DOI: 10.1002/cpt.2471
Abstract: Basic scientists and drug developers are accelerating innovations towards the goal of precision medicine. Regulators create pathways for timely patient access to precision medicines including individualized therapies. Healthcare payors acknowledge the need for change but… read more here.
Keywords: medicine; real world; track pay; reimbursement ... See more keywords
Soziale Rückvergütung – das Projekt „Lateinamerika“ der Spanisch-Deutschen HNO-Gesellschaft (SDGHNO)
Sign Up to like & getrecommendations! Published in 2019 at "HNO"
DOI: 10.1007/s00106-019-0698-3
Abstract: ZusammenfassungSoziale Projekte sind in der heutigen Zeit meist dermaßen ausgerichtet, dass sie sich nach einem vorgegebenen Zeitraum entweder eigenständig tragen können oder sogar eine pekuniäre Rückvergütung erlauben. In letzterem Fall spricht man in Fachkreisen von… read more here.
Keywords: spanisch; reimbursement; projekt lateinamerika; sdghno ... See more keywords
Comparison of surgical payer costs and implication on the healthcare expenses between laparoscopic magnetic sphincter augmentation (MSA) and laparoscopic Nissen fundoplication (LNF) in a large healthcare system
Sign Up to like & getrecommendations! Published in 2019 at "Surgical Endoscopy"
DOI: 10.1007/s00464-019-07021-4
Abstract: Introduction Magnetic sphincter augmentation (MSA) is a promising antireflux surgical treatment. The cost associated with the device may be perceived as a drawback by payers, which may limit the adoption of this technique. There are… read more here.
Keywords: surgery; payer costs; reimbursement; payer ... See more keywords
Geographic variation in Part B reimbursement and physician offsetting behavior: a physician matching approach
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Health Economics and Management"
DOI: 10.1007/s10754-021-09297-3
Abstract: Historically, Medicare has operated under the assumption that providers respond to reductions in reimbursement through increased provision of services in an effort to offset declining practice revenue; however, some recent empirical work examining fee reductions… read more here.
Keywords: part reimbursement; geographic variation; reimbursement; variation part ... See more keywords
Metastatic Renal Cell Cancer: An Analysis of Reimbursement Decisions
Sign Up to like & getrecommendations! Published in 2019 at "Advances in Therapy"
DOI: 10.1007/s12325-019-00947-0
Abstract: IntroductionMetastatic renal cell carcinoma is a complex cancer for which several drugs have been developed over the years. More recently, drugs that target the specific cancer cell mutations have been developed for metastatic cell carcinoma.… read more here.
Keywords: renal cell; cell carcinoma; reimbursement; reimbursement decisions ... See more keywords
Pricing and Reimbursement of Patent-Protected Medicines: Challenges and Lessons from South-Eastern Europe
Sign Up to like & getrecommendations! Published in 2021 at "Applied Health Economics and Health Policy"
DOI: 10.1007/s40258-021-00678-w
Abstract: Efficiency and transparency of pricing and reimbursement (P&R) rules and procedures as well as their implementation in South-eastern Europe (SEE) lag substantially behind Western European practice. Nevertheless, P&R systems in SEE are rarely critically assessed,… read more here.
Keywords: patent protected; reimbursement; protected medicines; pricing ... See more keywords
Money back guarantee? A cost–benefit framework of performance-based agreements (PBAs) for the reimbursement of pharmaceuticals
Sign Up to like & getrecommendations! Published in 2019 at "Eurasian Business Review"
DOI: 10.1007/s40821-018-0107-y
Abstract: The aim of this paper is to provide an empirical framework based on a discrete-time Markov chain to assess the costs and benefits of Performance Based Agreements (PBAs) for the reimbursement of pharmaceuticals. We provide… read more here.
Keywords: agreements pbas; framework; reimbursement; performance based ... See more keywords
The Impact of Infections on Reimbursement in 92 US Hospitals, 2015-2018.
Sign Up to like & getrecommendations! Published in 2021 at "American journal of infection control"
DOI: 10.1016/j.ajic.2021.04.007
Abstract: BACKGROUND The diagnosis-related group (DRG) is a payment system introduced to standardize healthcare costs. However, reimbursement for treatment of infections does not always cover costs. METHODS We used 2015-2018 data from 92 US hospitals in… read more here.
Keywords: impact; 2015 2018; infection; los days ... See more keywords